ASKING PRICE: $850,000 (ASSET PURCHASE)
Laboratory Nexus is representing a Texas-based, CLIA-certified diagnostic laboratory specializing in clinical chemistry, immunology, hematology, and molecular testing, including PCR-based infectious disease panels.
The laboratory is fully staffed and operational and has successfully passed its most recent CDPH and New York State inspections with zero deficiencies.
This offering provides an opportunity to acquire a turnkey laboratory with established infrastructure, equipment, systems, and personnel, allowing a buyer to begin operations without the time and expense associated with a new laboratory buildout.
FULLY EQUIPPED • TURNKEY LABORATORY • ASSET PURCHASE
ACQUISITION OVERVIEW
• Purchase Price: $850,000
• Transaction Type: Asset purchase
• Included Assets: Laboratory instrumentation, equipment, furniture, and infrastructure
• Current Business Volume: May be negotiated separately
• Operational Status: Fully operational
• Certification: CLIA-certified
• Inspection History: Recent CDPH and New York State inspections completed with zero deficiencies
• Reason for Sale: Owner is diversifying into other business ventures
OPERATIONAL SNAPSHOT
• Staff: 7 employees
• Facility Size: Approximately 2,500 square feet
• Equipment Ownership: Combination of owned and leased instrumentation
• Laboratory Information System: Furnished LIS
KEY INSTRUMENTATION
• Abbott Alinity CI, 2 units — Leased
• Abbott Ruby — Leased
• Sysmex UN3000 — Owned and financed
• Siemens Clinitek Status Plus — Owned
• Bio-Rad Opus 384+96 — Owned
• Abbott Immtox — Owned
• KingFisher Flex Extraction System — Owned
• Agena Biosciences MassARRAY Genotyping System — Owned
• K2 Scientific Refrigeration Units, 6 units — Includes –20°C, –80°C, and 2–8°C units
• Bio-Rad CFX384 Real-Time PCR System — Owned
• Fluidigm Juno NGS and Biomark HD — Owned
LABORATORY HIGHLIGHTS
• Approved for testing in all 50 states
• Turnkey laboratory with active operations
• High-complexity molecular diagnostics platform
• Recent CDPH and New York State inspections completed with zero deficiencies
• Experienced laboratory staff currently in place
• Extensive molecular, chemistry, hematology, and immunology instrumentation
• Suitable for an existing laboratory seeking to expand its capabilities
• Established platform for a new entrant into the clinical laboratory market
• Significantly reduces the cost and timeline associated with building a laboratory from the ground up
